Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: In: Haematologica - The hematology journal (2010) 95, 10, 1697-1704, DOI: 10.3324/haematol.2009.021428

Keyword: Medizin
Krebs
Onkologie

Event: Veröffentlichung

(where): Würzburg

(who): Universität Würzburg

(when): 2012

Creator: Geissinger, Eva
Sadler, Petra
Roth, Sabine
Grieb, Tina
Puppe, Bernhard
Mueller, Nora
Reimer, Peter
Vetter-Kauczok, Claudia S.
Wenzel, Joerg
Bonzheim, Irina
Ruediger, Thomas
Mueller-Hermelink, Hans Konrad
Rosenwald, Andreas

URN: urn:nbn:de:bvb:20-opus-68179

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Geissinger, Eva
Sadler, Petra
Roth, Sabine
Grieb, Tina
Puppe, Bernhard
Mueller, Nora
Reimer, Peter
Vetter-Kauczok, Claudia S.
Wenzel, Joerg
Bonzheim, Irina
Ruediger, Thomas
Mueller-Hermelink, Hans Konrad
Rosenwald, Andreas
Universität Würzburg

Time of origin

2012

Other Objects (12)

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

$Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma$

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Konferenzschrift

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

Hochschulschrift

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

$Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma$

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Konferenzschrift

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

Hochschulschrift

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

$Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma$

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Konferenzschrift

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

Hochschulschrift

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

T-cell receptor avidity of polyclonal CD8+ T-cell populations

Human T-cell clones

CAR T-Cell therapy

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report

The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia

Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Related objects

Reset password